[Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 1. In form of tablets].
D000208:Acute Disease; D000328:Adult; D000667:Ampicillin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D000996:Antitussive Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D001330:Electronic Data Processing; D005260:Female; D006140:Guaifenesin / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D008297:Male; D008499:Medical Records; D010208:Papaverine / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D013607:Tablets; D013806:Theophylline / Q000097:blood / Q000627:therapeutic use* / Q000652:urine
D000996:Antitussive Agents; D004338:Drug Combinations; D013607:Tablets; D006140:Guaifenesin; D000667:Ampicillin; D013806:Theophylline; D010208:Papaverine
Klinische Prüfung eines Kombinationspräparates aus Ampicillin, Theophyllin, Papaverin-HCl und Guajakolglycerinäther. 1. Mitteilung: In Form von Tabletten